Ceftriaxone-resistant Neisseria gonorrhoeae in Singapore: Eight years of sentinel surveillance
International Journal of STD & AIDS: Clinical practice in sexual health
Published online on March 30, 2026
Abstract
International Journal of STD & AIDS, Volume 37, Issue 8, Page 833-838, July 2026.
BackgroundCeftriaxone is currently the most frequently recommended first-line therapy for gonorrhoea globally. The emergence of ceftriaxone-resistantNeisseria gonorrhoeaethreatens effective control, yet longitudinal surveillance data remain limited in ...
BackgroundCeftriaxone is currently the most frequently recommended first-line therapy for gonorrhoea globally. The emergence of ceftriaxone-resistantNeisseria gonorrhoeaethreatens effective control, yet longitudinal surveillance data remain limited in ...